Výsledky vyhledávání - "Yuichiro Higaki"

Akademický článek

Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?

Autor: Muneyuki Masuda, Ryozaburo Nagata, Hirotaka Hara, Keiji Kuroki, Kuniaki Sato, Fumihide Rikimaru, Satoshi Toh, Yuichiro Higaki

Publikováno v: Clinical Case Reports, Vol 9, Iss 9, Pp n/a-n/a (2021)

Abstract Pembrolizumab and chemotherapy (chemoimmunotherapy) were administered to 2 head and neck squamous cell carcinoma (HNSCC) patients with extremely advanced local tumors and distant metastases with palliative intent. However, they demonstrated

Externí odkaz: https://doaj.org/article/ad63d38a85624d96bb38af156996edc8

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.

Publikováno v: PLoS ONE, Vol 13, Iss 6, p e0198391 (2018)

BACKGROUND:Chemoradiotherapy (CRT) has improved organ preservation or overall survival (OS) of locoregionally advanced head and neck squamous cell cancer (LAHNSCC), but in clinical trials of conventional CRT, increasing CRT intensity has not been sho

Externí odkaz: https://doaj.org/article/896019a6d4bb408999fe37aba4acb400

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.

Autor: Takeichiro Aso, Mioko Matsuo, Hideyuki Kiyohara, Kenichi Taguchi, Fumihide Rikimaru, Mototsugu Shimokawa, Yuichi Segawa, Yuichiro Higaki, Hirohito Umeno, Tadashi Nakashima, Muneyuki Masuda

Publikováno v: PLoS ONE, Vol 10, Iss 3, p e0116596 (2015)

At our institute, a chemoradioselection strategy has been used to select patients for organ preservation on the basis of response to an initial 30-40 Gy concurrent chemoradiotherapy (CCRT). Patients with a favorable response (i.e., chemoradioselected

Externí odkaz: https://doaj.org/article/e7988dacc6c145139d75b524f775537b

Zobrazit plný text záznamu

Akademický článek

Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC).

Publikováno v: PLoS ONE, Vol 10, Iss 2, p e0116965 (2015)

BACKGROUND:We conducted a phase III study to evaluate S-1 as compared with UFT as control in patients after curative therapy for stage III, IVA, or IVB squamous-cell carcinoma of the head and neck (SCCHN). PATIENTS AND METHODS:Patients were randomly

Externí odkaz: https://doaj.org/article/b87cbdb809e243b9a94df84f4227d8d7

Zobrazit plný text záznamu

Is chemoimmunotherapy a game changer in the treatment of locally advanced head and neck squamous cell carcinoma?

Autor: Fumihide Rikimaru, Keiji Kuroki, Hirotaka Hara, Yuichiro Higaki, Kuniaki Sato, Muneyuki Masuda, Satoshi Toh, Ryozaburo Nagata

Publikováno v: Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 9, Pp n/a-n/a (2021)

Pembrolizumab and chemotherapy (chemoimmunotherapy) were administered to 2 head and neck squamous cell carcinoma (HNSCC) patients with extremely advanced local tumors and distant metastases with palliative intent. However, they demonstrated strikingl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef136fb6b2e9cacd9367efc4b36d7015
http://europepmc.org/articles/PMC8457411

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání